Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome

Myeloperoxidase (MPO) and paraoxonase-1 (PON1) are inflammatory and anti-inflammatory enzymes, respectively that have been involved in the pathogenesis of coronary artery disease (CAD). In this study we sought to evaluate the relations of MPO and PON1 with high density lipoprotein (HDL) mean size in...

Full description

Bibliographic Details
Main Authors: Amirnader Emami Razavi, Gholam Basati, Jaleh Varshosaz, Soheila Abdi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2013-06-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://acta.tums.ac.ir/index.php/acta/article/view/4980/4385
_version_ 1828852728392056832
author Amirnader Emami Razavi
Gholam Basati
Jaleh Varshosaz
Soheila Abdi
author_facet Amirnader Emami Razavi
Gholam Basati
Jaleh Varshosaz
Soheila Abdi
author_sort Amirnader Emami Razavi
collection DOAJ
description Myeloperoxidase (MPO) and paraoxonase-1 (PON1) are inflammatory and anti-inflammatory enzymes, respectively that have been involved in the pathogenesis of coronary artery disease (CAD). In this study we sought to evaluate the relations of MPO and PON1 with high density lipoprotein (HDL) mean size in patients with acute coronary syndrome (ACS). Collectively, 50 control subjects and 50 patients with ACS were participated in this study. MPO level and PON1 activity was determined using immunoassay and colorimetric methods, respectively. HDL mean size was determined by a dynamic light scattering methodology. Other clinical risk factors were also determined by standard methods. The MPO/PON1 ratio amount was significantly higher in patients with ACS (1.49±1.10) than in control subjects (0.21±0.14) (P<0.01). There was a significant correlation between MPO/PON1 ratio and HDL mean size in patients with ACS. Amount of the enzymes and their relations to HDL particle size in patients with ACS may play a part in the pathogenesis of ACS. Also, MPO/PON1 ratio may be a robust predictor of ACS.
first_indexed 2024-12-12T23:59:29Z
format Article
id doaj.art-9b166d05b19e48158496c4a10b6c40e5
institution Directory Open Access Journal
issn 0044-6025
1735-9694
language English
last_indexed 2024-12-12T23:59:29Z
publishDate 2013-06-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-9b166d05b19e48158496c4a10b6c40e52022-12-22T00:06:27ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942013-06-01516365371Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary SyndromeAmirnader Emami RazaviGholam BasatiJaleh VarshosazSoheila AbdiMyeloperoxidase (MPO) and paraoxonase-1 (PON1) are inflammatory and anti-inflammatory enzymes, respectively that have been involved in the pathogenesis of coronary artery disease (CAD). In this study we sought to evaluate the relations of MPO and PON1 with high density lipoprotein (HDL) mean size in patients with acute coronary syndrome (ACS). Collectively, 50 control subjects and 50 patients with ACS were participated in this study. MPO level and PON1 activity was determined using immunoassay and colorimetric methods, respectively. HDL mean size was determined by a dynamic light scattering methodology. Other clinical risk factors were also determined by standard methods. The MPO/PON1 ratio amount was significantly higher in patients with ACS (1.49±1.10) than in control subjects (0.21±0.14) (P<0.01). There was a significant correlation between MPO/PON1 ratio and HDL mean size in patients with ACS. Amount of the enzymes and their relations to HDL particle size in patients with ACS may play a part in the pathogenesis of ACS. Also, MPO/PON1 ratio may be a robust predictor of ACS.http://acta.tums.ac.ir/index.php/acta/article/view/4980/4385HDL mean sizeMyeloperoxidaseParaoxonase-1
spellingShingle Amirnader Emami Razavi
Gholam Basati
Jaleh Varshosaz
Soheila Abdi
Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
Acta Medica Iranica
HDL mean size
Myeloperoxidase
Paraoxonase-1
title Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
title_full Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
title_fullStr Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
title_full_unstemmed Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
title_short Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
title_sort association between hdl particles size and myeloperoxidase paraoxonase 1 mpo pon1 ratio in patients with acute coronary syndrome
topic HDL mean size
Myeloperoxidase
Paraoxonase-1
url http://acta.tums.ac.ir/index.php/acta/article/view/4980/4385
work_keys_str_mv AT amirnaderemamirazavi associationbetweenhdlparticlessizeandmyeloperoxidaseparaoxonase1mpopon1ratioinpatientswithacutecoronarysyndrome
AT gholambasati associationbetweenhdlparticlessizeandmyeloperoxidaseparaoxonase1mpopon1ratioinpatientswithacutecoronarysyndrome
AT jalehvarshosaz associationbetweenhdlparticlessizeandmyeloperoxidaseparaoxonase1mpopon1ratioinpatientswithacutecoronarysyndrome
AT soheilaabdi associationbetweenhdlparticlessizeandmyeloperoxidaseparaoxonase1mpopon1ratioinpatientswithacutecoronarysyndrome